Philip Bejon
Director Modernising Medical Microbiology
I am Director of Modernising Medical Microbiology, co-leading with Sarah Walker. I was previously Director of the KEMRI-Wellcome Trust Research Programme, a collaborative Programme formed by the Kenya Medical Research Institute (KEMRI), Wellcome and University of Oxford. I am a clinician with specialist training in infectious disease. I have an interest in the evaluation of vaccines, including malaria, yellow fever and Ebola vaccines. I have undertaken studies of naturally acquired immunity to malaria and human challenge models, and have an interest in bone infection and osteomyelitis.
Recent publications
Widespread variants of the highly polymorphic Plasmodium falciparum vaccine candidate antigen MSP2 across Sub-Saharan Africa
Journal article
Zerebinski J. et al, (2026), The Journal of Infectious Diseases
Genomic Epidemiology of Multi-Modal ESBL Gene Transmission among Enterobacterales in a Neonatal Unit
Preprint
Parker MJ. et al, (2026)
Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity.
Journal article
Ogwang R. et al, (2026), Nature communications
African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.
Journal article
Muriuki JM. et al, (2026), Nature communications, 17
Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020–2025): Clinical Features and Wave Patterns
Journal article
Lambisia AW. et al, (2026), Open Forum Infectious Diseases, 13